Translational Research in Oncology (TRIO) at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
Translational Research in Oncology (TRIO) brings 2 presentations to SABCS 2026 in San Antonio, and exhibits at Booth 943. The cancer CRO presents a pooled analysis of relapse first in the brain after early breast cancer and an analysis of beta-blocker use in triple-negative disease treated with chemo-immunotherapy.
| Organization | SABCS 2026 Attendance |
|---|---|
Translational Research in Oncology (TRIO) Edmonton, Canada | |
Full-service contract research organization that runs cancer clinical trials with an international network of investigators and patient advocates. | Booth Exhibiting at Booth 943 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm Talk Wed Dec 9 7:30–7:33am |
Find decision makers at Translational Research in Oncology (TRIO)
Tell us what you sell and we’ll find the people at Translational Research in Oncology (TRIO) most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction